These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28640700)

  • 1. CNS Tumors in Neurofibromatosis.
    Campian J; Gutmann DH
    J Clin Oncol; 2017 Jul; 35(21):2378-2385. PubMed ID: 28640700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis.
    Korf BR
    Handb Clin Neurol; 2013; 111():333-40. PubMed ID: 23622184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system.
    Adamson DC; Rasheed BA; McLendon RE; Bigner DD
    Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors.
    Strowd RE
    Curr Treat Options Oncol; 2020 Aug; 21(10):81. PubMed ID: 32767156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seizures in neurofibromatosis. What is the risk?].
    Drouet A
    Rev Neurol (Paris); 2011 Dec; 167(12):886-96. PubMed ID: 22041820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing biologically targeted clinical trials for neurofibromatosis.
    Gutmann DH; Blakeley JO; Korf BR; Packer RJ
    Expert Opin Investig Drugs; 2013 Apr; 22(4):443-62. PubMed ID: 23425047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
    Karwacki MW; Woźniak W
    Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyneuropathy associated with neurofibromatosis].
    Drouet A; Créange A
    Rev Neurol (Paris); 2005 Mar; 161(3):275-83. PubMed ID: 15800448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis-associated nerve sheath tumors. Case report and review of the literature.
    Murovic JA; Kim DH; Kline DG
    Neurosurg Focus; 2006 Jan; 20(1):E1. PubMed ID: 16459989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities.
    Schulz A; Grafe P; Hagel C; Bäumer P; Morrison H; Mautner VF; Farschtschi S
    Exp Neurol; 2018 Jan; 299(Pt B):334-344. PubMed ID: 28587874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imaging features of neurofibromatosis type 2].
    Girard N
    J Neuroradiol; 2005 Jun; 32(3):198-203. PubMed ID: 16134301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis Type 2.
    Ardern-Holmes S; Fisher G; North K
    J Child Neurol; 2017 Jan; 32(1):9-22. PubMed ID: 27655473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from drug trials in neurofibromatosis: A systematic review.
    Dhaenens BAE; Ferner RE; Evans DG; Heimann G; Potratz C; van de Ketterij E; Kaindl AM; Hissink G; Carton C; Bakker A; Nievo M; Legius E; Oostenbrink R
    Eur J Med Genet; 2021 Sep; 64(9):104281. PubMed ID: 34237445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound assessment of peripheral nerve pathology in neurofibromatosis type 1 and 2.
    Winter N; Rattay TW; Axer H; Schäffer E; Décard BF; Gugel I; Schuhmann M; Grimm A
    Clin Neurophysiol; 2017 May; 128(5):702-706. PubMed ID: 28315612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis as a gateway to better treatment for a variety of malignancies.
    Bakker AC; La Rosa S; Sherman LS; Knight P; Lee H; Pancza P; Nievo M
    Prog Neurobiol; 2017 May; 152():149-165. PubMed ID: 26854064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurofibromatosis].
    Matthies C; Rampeltshammer E; Breun M
    Fortschr Neurol Psychiatr; 2023 May; 91(5):213-232. PubMed ID: 37192611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.